These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37704418)

  • 1. Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2.
    Lee ES; Suzuki Y; Tomioka H; Nakagami H; Sato Y
    Tohoku J Exp Med; 2023 Nov; 261(3):239-247. PubMed ID: 37704418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasohibin-2-Targeting Therapies for the Treatment of Pancreatic Ductal Adenocarcinoma.
    Suzuki Y; Sato Y
    Tohoku J Exp Med; 2024 Mar; 262(3):163-171. PubMed ID: 38220168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of vasohibin-2-targeting peptide vaccine for diabetic nephropathy.
    Nakashima Y; Tanabe K; Mifune T; Nakadoi T; Hayashi H; Nakagami H; Sato Y; Wada J
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F1054-F1065. PubMed ID: 38695075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial-mesenchymal transition via Hedgehog signaling pathway.
    Zhang Y; Xue X; Zhao X; Qin L; Shen Y; Dou H; Sun J; Wang T; Yang DQ
    Cancer Med; 2018 Nov; 7(11):5567-5576. PubMed ID: 30318866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization.
    Sun J; Tu M; Han B; Xue X; Zhang Y; Wei J; Chen J; Lu Z; An Y; Cai B; Lv N; Jiang K; Miao Y; Gao W
    Int J Oncol; 2013 Jul; 43(1):255-61. PubMed ID: 23615928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin-2.
    Horie S; Suzuki Y; Yamamoto T; Obika S; Mohri K; Kiyota C; Ren Q; Warashina S; Wada Y; Watanabe Y; Mukai H; Sato Y
    Cancer Sci; 2023 Sep; 114(9):3740-3749. PubMed ID: 37430466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.
    Suenaga K; Kitahara S; Suzuki Y; Kobayashi M; Horie S; Sugawara J; Yaegashi N; Sato Y
    PLoS One; 2014; 9(9):e104728. PubMed ID: 25184477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma.
    Iida-Norita R; Kawamura M; Suzuki Y; Hamada S; Masamune A; Furukawa T; Sato Y
    Cancer Sci; 2019 Jul; 110(7):2296-2308. PubMed ID: 31074083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].
    Wang J; Yu C; Jiang X; Wu X; Jia Y; Zhang H; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):966-975. PubMed ID: 35869758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasohibin 2 promotes epithelial-mesenchymal transition in human breast cancer via activation of transforming growth factor β 1 and hypoxia dependent repression of GATA-binding factor 3.
    Tu M; Li Z; Liu X; Lv N; Xi C; Lu Z; Wei J; Song G; Chen J; Guo F; Jiang K; Wang S; Gao W; Miao Y
    Cancer Lett; 2017 Mar; 388():187-197. PubMed ID: 27867016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.
    Koyanagi T; Suzuki Y; Komori K; Saga Y; Matsubara S; Fujiwara H; Sato Y
    Cancer Sci; 2017 Mar; 108(3):512-519. PubMed ID: 28032401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
    Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
    Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological Role of Vasohibin in Gastroenterological Cancers: A Meta-Analysis.
    Yamamoto M; Ozawa S; Koyanagi K; Ninomiya Y; Hara H; Kazuno A; Yatabe K; Higuchi T; Nakamura K; Nabeshima K; Sato Y
    Tohoku J Exp Med; 2022 Apr; 256(4):291-301. PubMed ID: 35296570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Xue X; Zhang Y; Zhi Q; Tu M; Xu Y; Sun J; Wei J; Lu Z; Miao Y; Gao W
    Cell Commun Signal; 2014 Oct; 12():62. PubMed ID: 25269476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome.
    Kim JC; Kim KT; Park JT; Kim HJ; Sato Y; Kim HS
    Hepatogastroenterology; 2015; 62(138):251-6. PubMed ID: 25916042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2.
    Tu M; Li H; Lv N; Xi C; Lu Z; Wei J; Chen J; Guo F; Jiang K; Song G; Gao W; Miao Y
    Mol Cancer; 2017 Mar; 16(1):66. PubMed ID: 28327155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasohibin-2 Aggravates Development of Ascending Aortic Aneurysms but not Abdominal Aortic Aneurysms nor Atherosclerosis in ApoE-Deficient Mice.
    Otaka N; Uchida HA; Okuyama M; Hada Y; Onishi Y; Kakio Y; Takeuchi H; Umebayashi R; Tanabe K; Subramanian V; Daugherty A; Sato Y; Wada J
    Am J Hypertens; 2021 May; 34(5):467-475. PubMed ID: 33180898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.